Health and Fitness Health and Fitness
Wed, April 23, 2025
Tue, April 22, 2025
[ Tue, Apr 22nd ] - Yahoo
The greatest sports movies

FDA stops sale of generic versions of Ozempic and Wegovy: What to do if you're taking them


Published on 2025-04-22 13:43:00 - Today
  Print publication without navigation

  • Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor explains options for patients.

The article discusses the increasing difficulty in accessing affordable generic versions of GLP-1 weight loss drugs like semaglutide and tirzepatide, which are popular for their effectiveness in weight management. These cheaper alternatives, often compounded from the same active ingredients as brand-name drugs like Ozempic and Mounjaro, have become scarce due to a surge in demand and regulatory actions by the FDA, which has raised concerns about the safety and efficacy of compounded drugs. The FDA has warned against using these compounded versions, leading to a reduction in their availability. For those currently using these medications, the article advises consulting healthcare providers to explore other treatment options, such as switching to the brand-name drugs if possible, or considering alternative weight loss strategies like diet and exercise, while also keeping an eye on future developments in the availability and regulation of these drugs.

Read the Full TODAY Article at:
[ https://www.msn.com/en-us/health/other/cheaper-copycat-glp-1-weight-loss-drugs-are-disappearing-what-to-do-if-youre-taking-them/ar-AA1DoZL5 ]